For this purpose, in this work, we genetically tested Sicilian male patients with MBC, PCa, PC and melanoma for germline BRCA1/2 PVs, in order to assess the type and prevalence of these high-risk susceptibility variants in individuals from the southernmost region of Italy. The gene discussed is BRCA1; the disease is melanoma.